Provides scalable, cost-effective manufacturing solutions for stable lentiviral vectors used in cell and gene therapies.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
iVexSol provides next-generation, scalable manufacturing solutions for the production of stable lentiviral vectors used in cell and gene therapies. The company’s platform enables rapid, cost-effective, and reliable vector supply for all stages of clinical development, helping to accelerate therapeutic programs and improve patient access to advanced treatments.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
iVexSol Management Team
Investors
Asahi-Kasei Corporation
BioLife Solutions
Bristol Myers Squibb
Casdin Capital
Charles River Laboratories
iVexSol Valuations & Financials
View real-time NPM data on iVexSol stock including daily iVexSol stock price estimates, valuation history, and historical share price information. Access iVexSol financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track iVexSol pricing across six independent market signals. Looking for private company due diligence data sources on iVexSol? Get in touch to learn more.
Similar Companies
like iVexSol
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
Block Renovation
Commerce & Marketplaces
Digital platform streamlines home renovations by matching homeowners with vetted contractors and providing end-to-end project management.
CureApp
Develops prescription digital therapeutic apps that deliver personalized treatment interventions for medical conditions through behavior modification.
Genotix
Healthcare & Life Sciences
Develops ultrasensitive nanoarray technology for single-molecule biomarker detection, enabling early disease identification and health monitoring.
VORAGO Technologies
Produces rugged, secure microcontrollers for high‑reliability applications.
Sionna
Healthcare & Life Sciences
Develops innovative medicines targeting CFTR protein function to advance treatment of cystic fibrosis through clinical research.
Momentus Space
Provides an in-space infrastructure and orbital logistics platform that utilizes proprietary water-propulsion vehicles.
Ring Therapeutics
Healthcare & Life Sciences
Develops gene therapy treatments using natural anelloviruses to create targeted, reusable therapeutic solutions for various medical conditions.
noodle.ai
Delivers AI-powered solutions that optimize business operations and supply chains through advanced analytics and machine learning.
FAQ
We have answers
iVexSol stock does not trade on public stock exchanges. iVexSol stock is considered a private security and you need to be an accredited investor to trade shares. To invest in iVexSol stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
iVexSol Stock does not trade on public stock exchanges. In order to sell iVexSol shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
iVexSol does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view iVexSol share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for iVexSol stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell iVexSol stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in iVexSol stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
iVexSol is a private company and has not had an IPO. There is currently no iVexSol IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to iVexSol IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
